Url Pharma

Jump to

Sun Pharma says seeks to enter Japan generics market

Sun also sought to take full control of its US-listed Israeli unit Taro Pharmaceutical Industries Ltd , but the deal was terminated last year after a long-drawn battle.
Sun Pharma: Can the stock climb higher than all-time high?

Sun Pharma was at lifetime high yesterday at Rs 854. It has received final approval for Novartis's Reclast/Aclasta, which is used in the treatment of osteoporosis.
Sun Pharma rises 1% on CLSA upgrade

Healthcare firm Sun Pharmaceutical Industries gained 1 percent on Wednesday as the foreign research house CLSA upgraded the stock to a buy rating with a target price of Rs 990.
Sun Pharma arm to buy Takeda's US-based generics subsidiary

Drug major Sun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsidiary URL Pharma.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Url Pharma

Sun Pharma says seeks to enter Japan generics market

Sun Pharma: Can the stock climb higher than all-time high?

Sun Pharma rises 1% on CLSA upgrade

Sun Pharma arm to buy Takeda's US-based generics subsidiary